US9229671048
US9229671048
Veradermics, Incorporated
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 5.47B EUR | 5.14B EUR | 2.36B EUR | -- |
Enterprise Value | 4.47B EUR | 4.82B EUR | 2.19B EUR | -- |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -48.71x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 6.72x | 6.31x | 6.04x | -- |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -- | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -1.52% | -3.37% | -- |